← Open Payments lookup

JEREMY ROLLINS: Open Payments

NPI 1659510147 · WINNSBORO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$678 in 39 payments from 13 companies in 2025. Trend: 2023 $828 · 2024 $705 · 2025 $678

Food & beverage: $678
CompanyPaymentsAmount
Lilly USA, LLC6$107
Otsuka America Pharmaceutical, Inc.5$102
Novo Nordisk Inc6$101
Astellas Pharma US Inc5$84
ABBVIE INC.4$78
Phathom Pharmaceuticals, Inc.3$41
Boehringer Ingelheim Pharmaceuticals, Inc.2$33
PFIZER INC.2$30
Amgen Inc.2$29
Bayer Healthcare Pharmaceuticals Inc.1$26

Products named: REXULTI, JARDIANCE, Veozah, VRAYLAR, Ozempic, MOUNJARO, VOQUEZNA, Rybelsus.

Industry payments across LA — which companies pay providers there.